The 2019 program is focused on CEOs and global industry leaders sharing their personal experiences and perspectives, including challenges and opportunities. The intimate format features fireside chats with seasoned global executives along with closed door CEO discussions supported by case studies based on pertinent issues. Some of the topics to be covered:
The Purposeful CEO Fireside Chat Series
Monday, July 8
| 2:00 pm | Registration Opens (Location: Carneros Lobby) |
| 5:00 pm |
Drinks and Falconry demonstration (Location: Carneros Courtyard) |
| 6:15 pm |
Opening Events (Location: Carneros Courtyard) Welcome Remarks: Sara Jane Demy, Founder & CEO, Demy-Colton Summit self-introductions |
| 7:15 pm |
Fireside Chat Series – The Purposeful CEO – Fulfilling the promise through company transformation
Moderator: Carin Canale-Theakston, Founder & CEO, CanaleComm Fireside CEO: Athena Countouriotis, President & CEO, Turning Point Therapeutics |
| 8:00 pm |
Networking Dinner Reception (Location: Sonoma – off of the Carneros Courtyard) |
Tuesday, July 9
| 7:15 am |
Breakfast (Location: Farm Dining Room) |
| 8:15 am |
Summit Overview & Rules of Engagement (Location for all discussions: Napa)
|
| 8:30 am |
The Pulse of Biotech: A balancing act A top line interactive dialogue on the state of the biotech industry, where it stands today, how it is impacting companies, and its future prospects. Discussion Leaders:
|
| 9:15 am |
Perspective Biotech: at cross-roads (case study): For leaders in the biotech industry, every success seems to bring on a new set of challenges. The Summit participants will receive case study background on a previously sleepy area of therapeutic development that is now becoming a hotbed of competition. The participants will be organized in teams and given their case study before the break. After the break, the teams meet to discuss their case study and develop recommendations for the CEO.
Discussion Leader:
|
| 9:30 am | Networking Break |
| 9:45 am |
Perspective Biotech Team Discussions: What should the CEO do? (Team breakout discussions) Instructions: Biotech leaders may have one of the most difficult general management roles in industry. They often reach the executive suite through a particular functional expertise (research, finance, commercial). Soon, however, they face challenges that require an integrated understanding of multiple disciplines. Each team will discuss a situation where a CEO must lead in an area that is outside of his/her comfort zone. The participants will be asked to develop recommendations for the CEO of their case study. |
| 10:30 am |
Teams Reconvene: Each team will present the specific challenges the CEO of their company faced and their recommendations for handling the situation.
Discussion Leaders:
|
| 11:30 am |
Spotlight: The pharma perspective: Optimizing pharma and biotech collaborations
Moderator: Mark Simon, Partner & Co-Founder, Torreya
|
| 12:15 pm |
Networking Lunch (Location: Farm Dining Room and Patio) |
| 1:15 pm |
BD Strategy: Managing your assets A 360 degree look at the cost and benefit of diversification.
Discussion Leaders:
|
| 2:00 pm |
Finance: Fueling your company with the right capital Understanding the costs of each source of capital and determining what the right mix is for your company.
Discussion Leaders:
|
| 3:00 pm |
Market Access: It’s always too early, until it’s too late – thinking globally & staying ahead of the game Market access has been a critical, and increasingly complex, issue in the industry for almost 20 years now, yet many leave planning to the last minute. Reimbursement is the key to operating cash flow for a medicine, a more accurate valuation and better alignment in business development discussions, yet many companies leave planning until after regulatory and clinical programs are finalized. Better and earlier access planning creates a better understanding of evidence and data needs for both payers and capital needs, more accurate net pricing estimates, and ultimately, a more realistic valuation model with fewer downside surprises.
Discussion Leaders:
|
| 3:45 pm |
Communications: Building Your Story – Crisis preparedness Every biotech CEO is responsible for communicating the company’s vision through good times and bad. This leadership role involves managing the challenges, getting everyone on the same page, and managing perception among the financial community, the trade media, and stakeholders. Every CEO will face adversity and uncertainty. When adversity strikes, how will you prioritize your response and who should you turn to for guidance internally and externally?
Discussion Leaders:
|
| 4:15 pm | Day 1 Wrap up |
| 4:30 pm | CEO Summit Games |
| 7:00 pm | Artisanal Wine Tasting (Location: Hilltop Patio) |
| 8:00 pm | Awards & Wine Country Dinner (Location: Hilltop Dining Room) |
| 9:30 pm | Dessert Reception (Location: Hilltop Library & Courtyard Firepit) |
Wednesday, July 10
| 7:30 am |
Breakfast (Location: Farm Dining Room) |
| 8:30 am |
Business and Boards: Forming a trusted relationship to support the success of the company Leading a company can be a turbulent ride in the biotech industry and as the CEO, you are judged by the people affiliated with you. How do you manage the ups and downs and approach attracting the right board members?
Discussion Leaders:
|
| 9:30 am |
Building a team smartly: The essentials for success The team surrounding a CEO is critical to the success of a company. How do you assess the strengths of your team to understand its weaknesses to identify your needs?
Discussion Leader:
|
| 10:15 am | Networking Break |
| 10:30 am |
CEO Spotlight: In conversation – It takes Perseverance!
|
| 11:30 am |
CEO Self- Assessment: Results and discussion
Discussion Leader:
|
| 12:00 pm |
Networking Lunch (Location: Farm Dining Room & Patio) |
| 1:00 pm |
Communication: The critical role of building and maintaining your company’s reputation Reputation matters to those that matter the most to our industry — patients, care providers, investors, employees, and potential hires (especially our increasingly millennial workforce). Positive reputations can pave the way in times of crisis, in times of transition – and when it’s critical to have a seat at the policy-setting table. How can the biotech industry improve our reputation – and our communication to consumers – and receive reputational value for the positive difference we make in the lives of millions?
Discussion Leaders:
|
| 2:00 pm |
An Unguarded Conversation Among Friends
Discussion Leaders:
|
| 3:00 pm |
Closing Reception (Location: Carneros Courtyard) |
